Current Controversies in Prenatal Diagnosis 2: NIPT results suggesting maternal cancer should always be disclosed
- PMID: 30398677
- PMCID: PMC6714972
- DOI: 10.1002/pd.5379
Current Controversies in Prenatal Diagnosis 2: NIPT results suggesting maternal cancer should always be disclosed
Conflict of interest statement
Conflicts of Interest: Peter Benn is a consultant to Natera, Inc.; Sharon Plon is on the scientific advisory panel of Baylor Genetics Laboratories; Diana Bianchi has no conflicts of interest.
Comment in
-
Non-invasive prenatal testing 10 years on.Prenat Diagn. 2021 Sep;41(10):1187-1189. doi: 10.1002/pd.6032. Prenat Diagn. 2021. PMID: 34418119 No abstract available.
References
-
- Mennuti MT, Cherry AM, Morrissette JJ, Dugoff L. Is it time to sound an alarm about false-positive cell-free DNA testing for fetal aneuploidy? Am J Obstet Gynecol 2013;209:415–9. - PubMed
-
- Pavlidis NA. Coexistence of pregnancy and malignancy. Oncologist 2002;7(4):279–87. - PubMed
-
- Dharajiya NG, Grosu DS, Farkas DH, et al. Incidental detection of maternal neoplasia in non-invasive prenatal testing. Clin Chem 2018;64(2):329–325. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
